Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep89 | Bone and Calcium | ECE2020

Cortisol secreting adrenal adenoma. A clinically silent cause of osteoporosis

Kostoglou-Athanassiou Ifigenia , ATHANASSIOU Lambros , Ginis Alexandros , Manta Erasmia , Tsakiridis Pavlos , Giannakopoulos Andreas , Pastroudis Alexandros , Athanassiou Panagiotis

Adrenal adenomas are nowadays frequently diagnosed in the context of abdominal imaging. Osteoporosis may be a presenting manifestation of a cortisol producing adrenal adenoma. The aim was to present two cases of patients diagnosed and treated for osteoporosis who later in the course of the disease were diagnosed with a cortisol producing adrenal adenoma. Two patients, female aged 53 and 56 years, respectively, presented with osteoporosis. T score was −2.8 and &#...

ea0070ep118 | Bone and Calcium | ECE2020

Periodontitis and osteoporosis. A frequent coexistence with dangerous implications

Kostoglou–Athanassiou Ifigenia , Athanassiou Lambros , Spyropoulos Panagiotis , Manta Erasmia , Mavroudi Maria , Giannakopoulos Andreas , Pastroudis Alexandros , Athanassiou Panagiotis

Periodontitis is a serious medical condition which may lead to edentulousness in middle aged patients. It is a chronic inflammatory systemic disorder which affects the oral cavity, the maxilla and mandible. It may be associated with osteoporosis. It presents unique problems in the management of osteoporosis. The patients are in the imminent danger of losing teeth. Some of the antiosteoporotic agents may induce osteonecrosis, while they may complicate the implantation of dental...

ea0070ep130 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Similar effect of tocilizumab, an interleukin-6 receptor antagonist, administered either intravenously or subcutaneously on lipid levels in rheumatoid arthritis

Athanassiou Panagiotis , Athanassiou Lambros , Tzanavari Aikaterini , Gatsiou Marina , Devetzi Eirini , Tsakiridis Pavlos , Mavroudi Maria , Kostoglou-Athanassiou Ifigenia

Tocilizumab is an interleukin-6 receptor antagonist used in the treatment of rheumatoid arthritis (RA). It is known to induce remission and inhibit radiographic progression in RA. Tocilizumab may be administered either intravenously or subcutaneously. Its effect on lipid levels and the cardiovascular risk has not been fully investigated. The aim was to study the effect of tocilizumab administered either iv or sc on disease activity, lipid levels and cardiovascular risk in RA p...

ea0073aep130 | Calcium and Bone | ECE2021

The benign course of MEN I disease. Implications for treatment

Athanassiou Lambros , Kostoglou-Athanassiou Ifigenia , Spyropoulos Panagiotis , Xanthakou Eleni , Mascha Olga , Fortis Athanasios , Kalogirou Thomais , Athanassiou Panagiotis

MEN (multiple endocrine neoplasia) I disease represents a compilation of multiple endocrine neoplasms affecting a patient in the course of a life-time. It thus represents a phenotype which has survived over many years. Pituitary neoplasms, lipomas and parathyroid hyperplasia are observed in the disease. The aim was to describe a patient with MEN I disease who presented with lipomas and acromegaly in his early adulthood and developed primary hyperparathyroidism in his senior ye...

ea0090p374 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

The Effect of Diabetes Mellitus on the Outcome of Sars-Cov-2 Infection

Moschopoulos Theodoros , Athanassiou Panagiotis , Athanasiou Ifigenia Kostoglou

Introduction: Infection from the severe respiratory distress syndrome coronavirus 2 (SARS-CoV-2) virus may present as mild disease or as severe disease with high mortality. Although the majority of patients infected by the virus have a good prognosis, chronic diseases, such as diabetes mellitus (DM), especially in older adults may be a risk factor for a worse outcome. DM is a frequent comorbidity in patients with COVID-19. Aim: The aim of the present wor...

ea0029p1718 | Thyroid (non-cancer) | ICEECE2012

Stessful life events and Graves’ disease

Kostoglou-Athanassiou I. , Gkountouvas A. , Kaldrymides P.

Stress appears to activate the immunoneuroendocrine network and seems to be related to the development of autoimmune diseases. Graves’ disease is a multisystem disorder characterized by hyperthyroidism, eye disease and pretibial myxedema. Stress appears also to be related to the development of Graves’ disease.The aim was to describe cases of Graves’ disease which developed immediately after a stressful life event.Pat...

ea0090ep103 | Adrenal and Cardiovascular Endocrinology | ECE2023

Steroid hormone withdrawal and autoimmunity induction

Athanassiou Lambros , Athanassiou Panagiotis , Kalavri Eleni , Tsakiridis Pavlos , Fortis Athanasios , Mascha Olga , Ifigenia Kostoglou Athanasiou

Introduction: Pregnancy is characterized by increased secretion of estrogens and cortisol. Estrogen is used to prepare the maternal environment for the fetus. Cortisol induces a state of immunosuppression to avoid loss of the fetus, which, by definition, is at least partly a foreign organism. Parturition is characterized by estrogen and cortisol withdrawal. It leads to a rebound in immunity and may be accompanied by the development of autoimmune disease. Autoimmune thyroid dis...

ea0090ep1071 | Thyroid | ECE2023

Transverse Myelitis and Covid-19 Disease in A Patient with Hashimoto’s Thyroiditis

Athanassiou Lambros , Athanassiou Panagiotis , Tsakiridis Pavlos , Nikolakopoulou Sofia , Mathiou Dimitra , Nikolidaki Maria , Athanasiou Ifigenia Kostoglou

Introduction: The SARS-CoV-2 virus has caused the recent pandemic. Most affected patients have gone through a rather mild disease. However, some of the patients have gone through a severe illness requiring admission to an acute care unit. Some survived while others succumbed to the disease. In some patients the SARS-CoV-2 infection was characterized by neurological manifestations. One of these is transverse myelitis thought to be caused either by the virus itself as the SARS-C...

ea0041gp39 | Bone & Calcium Homeostasis | ECE2016

Drug holiday in osteoporosis. reducing side effects of long lasting treatments

Athanassiou Panagiotis , Pantazi Eleni , Skioti Ourania , Tzanavari Aikaterini , Kostoglou-Athanassiou Ifigenia

Introduction: Osteoporosis is a chronic and dangerous disease, as it may be silent and may express itself with a sudden catastrophic event, such as a fracture. Treatment of osteoporosis demands the use of potent pharmaceutical agents with long lasting effects. In particular, bisphosphonates, such as ibandronate, may be used. It has become evident that chronic treatment with anti-osteoporotic agents may reverse the course of the disease, patients having normal bone mineral dens...

ea0041ep131 | Bone & Osteoporosis | ECE2016

Barrett’s esophagus and osteopenia: Report of a case

Athanassiou Panagiotis , Tzanavari Aikaterini , Spyridis Anestis , Kostopoulos Markos , Xanthakou Eleni , Kostoglou-Athanassiou Ifigenia

Introduction: Barrett’s esophagus is metaplasia in the cells of the lower end of the esophagus. It is characterized by the replacement of the normal stratified squamous epithelium lining of the esophagus by simple columnar epithelium with goblet cells. The disease is often related to gastroesophageal reflux and patients have pain necessitating chronic usage of proton pump inhibitors. Proton pump inhibitors have been associated with the development of low bone mineral dens...